Tocagen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Tocagen Inc (Tocagen) focuses on the development and commercialization of cancer treating products. The company offers products such as Toca 511, Toca FC and Toca RNAi. Its Toca 511 is a component which allows selective targeting of cancer cells. Its products are used in combination with Toca FC, which is a tablet containing 5-FC. Tocagen develops retroviral non-replicating vectors designed to activate the immune system selectively against the tumor. The companys controlled active gene transfer technology is a retroviral replicating vector carrying out the complement of viral genes, and allows viral replication and subsequent delivery of therapeutic gene throughout a tumor. Tocagen is headquartered in San Diego, California, the US.
Tocagen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Tocagen Inc (Tocagen) focuses on the development and commercialization of cancer treating products. The company offers products such as Toca 511, Toca FC and Toca RNAi. Its Toca 511 is a component which allows selective targeting of cancer cells. Its products are used in combination with Toca FC, which is a tablet containing 5-FC. Tocagen develops retroviral non-replicating vectors designed to activate the immune system selectively against the tumor. The companys controlled active gene transfer technology is a retroviral replicating vector carrying out the complement of viral genes, and allows viral replication and subsequent delivery of therapeutic gene throughout a tumor. Tocagen is headquartered in San Diego, California, the US.
Tocagen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Tocagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tocagen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tocagen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tocagen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tocagen Inc, Medical Devices Deals, 2011 to YTD 2017 9
Tocagen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tocagen Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Tocagen Raises USD2.73 Million in Venture Financing 11
Tocagen Raises USD8.3 Million in Extended Venture Financing 11
Tocagen Raises US$0.2 Million In Venture Financing 12
Tocagen Raises Additional US$8 Million In Venture Financing 12
Tocagen Raises US$15 Million In Venture Financing 13
Partnerships 14
RiboMed Biotech Enters into Research Agreement with Tocagen 14
Equity Offering 14
NanoCarrier Agrees to Invest in Tocagen 14
Tocagen Raises USD97.8 Million in IPO 15
Tocagen Inc - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Mar 07, 2017: Tocagen Appoints Mark Foletta as Executive Vice President and Chief Financial Officer 20
Nov 02, 2016: Tocagen Strengthens Leadership Team: Martin Duvall Appointed as Chief Executive Officer 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
Tocagen Inc, Pharmaceuticals & Healthcare, Key Facts 1
Tocagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tocagen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tocagen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tocagen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Tocagen Inc, Medical Devices Deals, 2011 to YTD 2017 9
Tocagen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tocagen Raises USD2.73 Million in Venture Financing 11
Tocagen Raises USD8.3 Million in Extended Venture Financing 11
Tocagen Raises US$0.2 Million In Venture Financing 12
Tocagen Raises Additional US$8 Million In Venture Financing 12
Tocagen Raises US$15 Million In Venture Financing 13
RiboMed Biotech Enters into Research Agreement with Tocagen 14
NanoCarrier Agrees to Invest in Tocagen 14
Tocagen Raises USD97.8 Million in IPO 15
Tocagen Inc, Key Competitors 17
Tocagen Inc, Key Employees 18
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23
Table of Contents 2
List of Tables 3
List of Figures 4
Tocagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tocagen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tocagen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tocagen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tocagen Inc, Medical Devices Deals, 2011 to YTD 2017 9
Tocagen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tocagen Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Tocagen Raises USD2.73 Million in Venture Financing 11
Tocagen Raises USD8.3 Million in Extended Venture Financing 11
Tocagen Raises US$0.2 Million In Venture Financing 12
Tocagen Raises Additional US$8 Million In Venture Financing 12
Tocagen Raises US$15 Million In Venture Financing 13
Partnerships 14
RiboMed Biotech Enters into Research Agreement with Tocagen 14
Equity Offering 14
NanoCarrier Agrees to Invest in Tocagen 14
Tocagen Raises USD97.8 Million in IPO 15
Tocagen Inc - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Mar 07, 2017: Tocagen Appoints Mark Foletta as Executive Vice President and Chief Financial Officer 20
Nov 02, 2016: Tocagen Strengthens Leadership Team: Martin Duvall Appointed as Chief Executive Officer 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List Of Tables
Tocagen Inc, Pharmaceuticals & Healthcare, Key Facts 1
Tocagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tocagen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tocagen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tocagen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Tocagen Inc, Medical Devices Deals, 2011 to YTD 2017 9
Tocagen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tocagen Raises USD2.73 Million in Venture Financing 11
Tocagen Raises USD8.3 Million in Extended Venture Financing 11
Tocagen Raises US$0.2 Million In Venture Financing 12
Tocagen Raises Additional US$8 Million In Venture Financing 12
Tocagen Raises US$15 Million In Venture Financing 13
RiboMed Biotech Enters into Research Agreement with Tocagen 14
NanoCarrier Agrees to Invest in Tocagen 14
Tocagen Raises USD97.8 Million in IPO 15
Tocagen Inc, Key Competitors 17
Tocagen Inc, Key Employees 18
List Of Figures
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23
RELATED REPORTS
Binx Health Inc - Product Pipeline Analysis, 2021 Update
Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for womens health. The company develops its
View ReportProfound Medical Inc - Product Pipeline Analysis, 2021 Update
Profound Medical Inc (Profound Medical) is a medical device company that develops and markets solutions to deliver precise ablation of prostate. Its proprietary technology, TULSA-PRO, by combining real-time magnetic resonance
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
